We categorised K6 scores as no/low distress (04) or moderate/severe distress ( 5) [35, 37]
Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives
No, it is not safe to use Wegovy during pregnancy
its intricately linked to hormonal fluctuations, particularly a dip in oestrogen levels
Skin: Apply a gentle, antioxidant-rich mask post-sauna
Wayhs CAY, Manfredini V, Sitta A, Deon M, Ribas G, Vanzin C, et al